send mail to support@abhimanu.com mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
By Loging in you agree to Terms of Services and Privacy Policy
Please specify
Please verify your mobile number
Login not allowed, Please logout from existing browser
Please update your name
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Your Free user account at abhipedia has been created.
Remember, success is a journey, not a destination. Stay motivated and keep moving forward!
Refer & Earn
Enquire Now
My Abhipedia Earning
Kindly Login to view your earning
Support
The revision of antibiotics classes by the World Health Organisation in its list of essential medicines is a welcome step in the global initiative to push back against antimicrobial resistance, the phenomenon of bacteria becoming resistant even to the most potent drugs. The updated list of 433 drugs deemed essential for addressing the most important public health needs.
Analysis:
With a graded approach to the use of antibiotics, under which some medicines are reserved for the most resistant microbes, the WHO list can stop their misuse as broad-spectrum treatments.
The revised WHO classification can mitigate the problem if the many issues associated with use of the drugs can be monitored and regulated.
One of the key aspects of the WHO’s guidance is the availability of a first-line ‘access’ group of antibiotics at all times. Other drugs are placed under a ‘watch’ category as second choice, or as ‘reserve’ to be deployed as a last resort.
The medical community can be sensitized to its responsibility to prevent antimicrobial resistance; it will take enlightened policies on housing, sanitation and hygiene education to prevent new infections and the spread of disease-causing organisms.
This list is a new tool to ensure R&D responds to urgent public health need. The list is intended to spur governments to put in place policies that incentivize basic science and advanced R&D by both publicly funded agencies and the private sector.
Conclusion:
Drug-resistant microbes pose a serious challenge today to treat.The quest for new classes of drugs goes on. An effective response demands scrupulous adherence to prescription discipline of the kind advocated by the WHO. India has severe asymmetries in the delivery of health care: rural-vs-urban and poor-vs-affluent patients.It will take good public health policies, sufficient funding and determined leadership to overcome antibiotic resistance.
By: Harman Sandhu ProfileResourcesReport error
Access to prime resources